ClinicalTrials.Veeva

Menu

Effects of Plasmapheresis on Aging Biomarkers

C

Charles University, Czech Republic

Status

Completed

Conditions

Plasmapheresis
Aging

Treatments

Procedure: Plasmapheresis

Study type

Observational

Funder types

Other

Identifiers

NCT05004220
202103 P07

Details and patient eligibility

About

The aim of the study is to evaluate the effect of plasmapheresis (repeated plasma withdrawals) on selected health indicators (hematological, biochemical, immunological and indicators of biological age) of plasma donors.

Enrollment

41 patients

Sex

All

Ages

40 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Generally healthy volunteer subjects age 40 - 60
  2. 50:50 man and woman

Exclusion criteria

  1. Subjects excluded from plasma donation protocols (serious illness, infection, etc)
  2. Subjects undergoing stronger anti-aging interventions

Trial design

41 participants in 2 patient groups

Group 1
Description:
Group 1 consists of first time donors undergoing all 8 tracked plasmaphereses.
Treatment:
Procedure: Plasmapheresis
Group 2
Description:
Group 2 consists of first time donors undergoing only last 4 plasmaphereses, serving as control for the first 4 donations.
Treatment:
Procedure: Plasmapheresis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems